1984 Volume 32 Issue Supplement9 Pages 213-216
AC-1370 was given to 10 patients, 7 of respiratory tract infections, 2 of urinary tract infections and 1 of biliary tract infection. The drug was administered intravenously by drip infusion at daily dose of 1, 000mg or 2, 000mg.
1) Efficacy rate was counted 86.7% in RTI, 100% in UTI and biliary tract infection. The overall efficacy rate was 90%.
2) No clinical adverse effect and no abnormality of laboratory findings were observed.